This 230-year-old Japanese drugmaker is trying to transform itself into 'a 33,000 person startup'

Courtesy Bruno Villetelle Takeda, a Japanese pharmaceutical company that targets diseases like cancer and diabetes, has big plans to make itself more global and, at the same time, digital-focused.  To get a better sense of what that would look like, Business Insider spoke with Takeda's Chief Digital Officer Bruno Villetelle about his plans to integrate technology into the heart of a 230-year-old health company. Though no official deals have been announced yet, the company is exploring partners...